Fennec Pharmaceuticals Statistics
Total Valuation
FENC has a market cap or net worth of $373.42 million. The enterprise value is $333.24 million.
| Market Cap | 373.42M |
| Enterprise Value | 333.24M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FENC has 34.74 million shares outstanding. The number of shares has increased by 10.35% in one year.
| Current Share Class | 34.74M |
| Shares Outstanding | 34.74M |
| Shares Change (YoY) | +10.35% |
| Shares Change (QoQ) | +14.03% |
| Owned by Insiders (%) | 3.44% |
| Owned by Institutions (%) | 17.59% |
| Float | 16.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.33 |
| PS Ratio | 7.32 |
| Forward PS | 4.91 |
| PB Ratio | 9.86 |
| P/TBV Ratio | 9.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.98
| Current Ratio | 6.98 |
| Quick Ratio | 6.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.62 |
Financial Efficiency
Return on equity (ROE) is -52.68% and return on invested capital (ROIC) is -13.67%.
| Return on Equity (ROE) | -52.68% |
| Return on Assets (ROA) | -5.91% |
| Return on Invested Capital (ROIC) | -13.67% |
| Return on Capital Employed (ROCE) | -8.99% |
| Weighted Average Cost of Capital (WACC) | 10.13% |
| Revenue Per Employee | $1.46M |
| Profits Per Employee | -$239,286 |
| Employee Count | 35 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, FENC has paid $106,000 in taxes.
| Income Tax | 106,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.44% in the last 52 weeks. The beta is 1.07, so FENC's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +22.44% |
| 50-Day Moving Average | 9.22 |
| 200-Day Moving Average | 8.16 |
| Relative Strength Index (RSI) | 63.29 |
| Average Volume (20 Days) | 276,877 |
Short Selling Information
The latest short interest is 488,731, so 1.41% of the outstanding shares have been sold short.
| Short Interest | 488,731 |
| Short Previous Month | 450,578 |
| Short % of Shares Out | 1.41% |
| Short % of Float | 2.90% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, FENC had revenue of $51.00 million and -$8.38 million in losses. Loss per share was -$0.28.
| Revenue | 51.00M |
| Gross Profit | 47.04M |
| Operating Income | -5.59M |
| Pretax Income | -8.27M |
| Net Income | -8.38M |
| EBITDA | -5.49M |
| EBIT | -5.59M |
| Loss Per Share | -$0.28 |
Balance Sheet
The company has $40.18 million in cash and n/a in debt, with a net cash position of $40.18 million or $1.16 per share.
| Cash & Cash Equivalents | 40.18M |
| Total Debt | n/a |
| Net Cash | 40.18M |
| Net Cash Per Share | $1.16 |
| Equity (Book Value) | 37.68M |
| Book Value Per Share | 1.09 |
| Working Capital | 57.29M |
Cash Flow
| Operating Cash Flow | -5.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 102,667 |
| Net Borrowing | -19.48M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 92.23%, with operating and profit margins of -10.97% and -16.42%.
| Gross Margin | 92.23% |
| Operating Margin | -10.97% |
| Pretax Margin | -16.21% |
| Profit Margin | -16.42% |
| EBITDA Margin | -10.77% |
| EBIT Margin | -10.97% |
| FCF Margin | n/a |
Dividends & Yields
FENC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.35% |
| Shareholder Yield | -10.35% |
| Earnings Yield | -2.24% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for FENC is $15.67, which is 45.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.67 |
| Price Target Difference | 45.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 44.78% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2014. It was a reverse split with a ratio of 1:3.
| Last Split Date | Sep 5, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
FENC has an Altman Z-Score of 1.1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 4 |